Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 open-label single-arm study of amphotericin B cholesteryl sulfate complex for invasive candidiasis and invasive aspergillosis
ChiCTR2000028942Phase 2Not yet recruiting
- Sponsor
- Huashan Hospital
- Start
- Mar 2020
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of amphotericin b cholesteryl sulfate complex in invasive candidiasis and invasive aspergillosis (IA), sponsored by Huashan Hospital. Primary endpoints: Alanine aminotransferase, Blood potassium and 2 more. Planned start Mar 2020; status: not yet recruiting.
02
Drugs
amphotericin b cholesteryl sulfate complex
03
Conditions
invasive candidiasisinvasive aspergillosis (IA)
Beyond the preview
Go deeper on ChiCTR2000028942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000028942.